During the past decade, Genesis Research International conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Genesis Research International" #1 sponsor was "Pfizer" with 5 trials, followed by "Wellstat Therapeutics" with 2 trials sponsored, "Meda Pharmaceuticals" with 1 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored and "Pharmos" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Genesis Research International" #1 collaborator was "Hormos Medical" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Genesis Research International" are "Osteoarthritis" (4 trials), "Arthritis" (2 trials), "Type 2 Diabetes Mellitus" (2 trials), "Arthritis, Rheumatoid" (1 trials) and "Erectile Dysfunction" (1 trials). Many other conditions were trialed in "Genesis Research International" in a lesser frequency.

Most popular intervention types in "Genesis Research International" are "Drug" (9 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Naproxen" (2 trials), "PN2034" (2 trials), "placebo" (2 trials) and "tanezumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Genesis Research International" are 9 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Genesis Research International". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Genesis Research International, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Genesis Research International, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".